Results 251 to 260 of about 1,262,664 (328)

Next‐generation proteomics improves lung cancer risk prediction

Molecular Oncology, EarlyView.
This is one of very few studies that used prediagnostic blood samples from participants of two large population‐based cohorts. We identified, evaluated, and validated an innovative protein marker model that outperformed an established risk prediction model and criteria employed by low‐dose computed tomography in lung cancer screening trials.
Megha Bhardwaj, Clara Frick, Ben Schöttker, Bernd Holleczek, Hermann Brenner   +4 more
wiley   +1 more source

Elucidate biomarkers and the molecular pathways associated with genetic variants that contribute to the etiology of Parkinson's disease. [PDF]

Acta Neurol Belg
Nguyen HD.
europepmc   +1 more source

Biochemical and Genetical Studies on Variants of the Mouse Strain L Cells in Cell Culture

, 1961
Masakatsu Horikawa
openalex   +2 more sources

Potential therapeutic targeting of BKCa channels in glioblastoma treatment

Molecular Oncology, EarlyView.
This review summarizes current insights into the role of BKCa and mitoBKCa channels in glioblastoma biology, their potential classification as oncochannels, and the emerging pharmacological strategies targeting these channels, emphasizing the translational challenges in developing BKCa‐directed therapies for glioblastoma treatment.
Kamila Maliszewska‐Olejniczak, Karolina Pytlak, Sandra Jaworowska, Bogusz Kulawiak, Piotr Bednarczyk   +4 more
wiley   +1 more source

Association Between Genetic Variants in <i>DEFB1</i> Gene and Dental Caries Susceptibility. [PDF]

Int J Dent
Mokhtari MJ, Koohpeima F, Hashemi-Gorji F, Mirfakhraie R, Yassaee VR, Marjani M, Varahram M, Rezaei-Tavirani M, Omidifar N, Rezaei M.   +9 more
europepmc   +1 more source

Genetic variants and smoking progression in Chinese adolescents

, 2015
Sun, Wei (author)
openalex   +1 more source

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

Molecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute, Júlia Huguet‐Pradell, Jordi Abril‐Fornaguera, Albert Gris‐Oliver, Alex Rialdi, Elisa Fernández‐Martínez, Carla Montironi, Vanessa Del Pozo, Peter Houghton, Laura Zanatto, Agavni Mesropian, Ieva Keraite, Swan Thung, Carolina Armengol, Pau Sancho‐Bru, Ernesto Guccione, Roser Pinyol, Josep M. Llovet   +17 more
wiley   +1 more source

Genetic Variants in DVL3 are Associated With Root Maldevelopment, Tooth Agenesis, Mesiodens, and Oral Exostoses. [PDF]

Int Dent J
Kantaputra P, Bunpiem N, Guven Y, Tripuwabhrut K, Kalayci T, Imren E, Sengtae N, Pianmee C, Pruksametanan A, Tongsima S, Ngamphiw C, Kawasaki K, Ohazama A, Cairns JRK.   +13 more
europepmc   +1 more source